| Literature DB >> 34122601 |
Fu-Gui Liu1, Ai-Hua Tan2, Chao-Qun Peng3, Yun-Xia Tan1, Ming-Chao Yao1,4.
Abstract
OBJECTIVE: To systematically evaluate the efficacy and safety of scalp acupuncture in the treatment of insomnia.Entities:
Year: 2021 PMID: 34122601 PMCID: PMC8166479 DOI: 10.1155/2021/6621993
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Search strategy.
| #1 insomnia [Title/abstract] |
| #2 agrypnia [Title/abstract] |
| #3 hyposomnia [Title/abstract] |
| #4 sleeplessness [Title/abstract] |
| #5 sleep disorder [Title/abstract] |
| #6 dyssomnia [Title/abstract] |
| #7 #1 OR #2 OR #3 OR #4 OR #5 OR #6 |
| #8 insomnia [MeSH terms] |
| #9 agrypnia [MeSH terms] |
| #10 hypersomnia [MeSH terms] |
| #11 sleeplessness [MeSH terms] |
| #12 sleep disorder [MeSH terms] |
| #13 dyssomnia [MeSH terms] |
| #14 #8 OR #9 OR #10 OR #11 OR #12 OR #13 |
| #15 #7 OR #14 |
| #16 scalp acupuncture [Title/abstract] |
| #17 head acupuncture [Title/abstract] |
| #18 scalp-acupuncture [Title/abstract] |
| #19 #16 OR #17 OR #18 |
| #20 scalp acupuncture [MeSH terms] |
| #21 head acupuncture [MeSH terms] |
| #22 scalp-acupuncture [MeSH terms] |
| #23 #20 OR #21 OR #22 |
| #24 #19 OR #23 |
| #25 random [MeSH terms] |
| #26 stochastic [MeSH terms] |
| #27 randomly [MeSH terms] |
| #28 #25 OR #26 OR #27 |
| #29 random [Title/abstract] |
| #30 randomly [Title/abstract] |
| #31 stochastic [Title/abstract] |
| #32 #29 OR #30 OR #31 |
| #33 #28 OR #32 |
| #34 #15 AND #24 AND #33 |
Figure 1Flow chart of literature screening.
Basic information of the included literatures.
| First author | Year of publication | Languages | Interventions | Number of cases | Course of treatment | Outcome indicators | ||
|---|---|---|---|---|---|---|---|---|
| Treatment group | Control group | Treatment group | Control group | |||||
| Dong | 2018 | English | Scalp acupuncture | No treatment | 20 | 20 | 28 days | ①② |
| Jianpian Dong | 2008 | Chinese | Scalp acupuncture | Routine acupuncture | 36 | 35 | 30 days | ①② |
| Zhangling Zhou | 2010 | Chinese | Scalp acupuncture | Routine acupuncture | 35 | 35 | 28 days | ①② |
| Yingzhen Li | 2011 | Chinese | Scalp acupuncture | Body acupuncture | 87 | 86 | 28 days | ①②③ |
| Lianhe Dong | 2012 | Chinese | Scalp acupuncture | Body acupuncture | 24 | 24 | 28 days | ①② |
| Zhiqing le | 2020 | Chinese | Scalp acupuncture | Right left picrolon | 30 | 30 | 30 days | ①②③ |
| Zhiqiang Zhang | 2010 | Chinese | Scalp acupuncture | Routine acupuncture | 28 | 28 | 30 days | ①② |
| Jiakun Cao | 2013 | Chinese | Scalp acupuncture | Routine acupuncture | 35 | 35 | 30 days | ①② |
| Xuanting gu | 2013 | Chinese | Scalp acupuncture | Estazolam | 30 | 30 | 14 days | ①② |
| Qiuhe Zhao | 2014 | Chinese | Scalp acupuncture | Estazolam and oryzanol | 51 | 51 | 20 days | ①② |
| Xinhao Li | 2018 | Chinese | Scalp acupuncture | Routine acupuncture | 30 | 30 | 28 days | ①② |
| Jiali Tang | 2016 | Chinese | Scalp acupuncture | Routine acupuncture | 50 | 50 | 30 days | ①②③ |
| Yu Shi | 2020 | Chinese | Scalp acupuncture | Diazepam | 40 | 40 | 21 days | ①② |
| Linna Huang | 2011 | Chinese | Scalp acupuncture | Estazolam | 30 | 30 | 20 days | ①② |
| Yufang Hong | 2017 | Chinese | Scalp acupuncture | Routine acupuncture | 30 | 30 | 28 days | ② |
| Zhibin Liu | 2007 | Chinese | Scalp acupuncture | Clonazepam | 80 | 80 | 28 days | ①② |
| Yingying Mao | 2012 | Chinese | Scalp acupuncture | Routine acupuncture | 33 | 33 | 28 days | ①②③ |
| Daopeng Lai | 2015 | Chinese | Scalp acupuncture | Estazolam | 30 | 30 | 7 days | ①② |
| Jinchen Lu | 2013 | Chinese | Scalp acupuncture | Body acupuncture | 37 | 37 | 40 days | ② |
| Hui Kang | 2015 | Chinese | Scalp acupuncture | Estazolam | 35 | 35 | 28 days | ①②③ |
| Xiaopei Feng | 2014 | Chinese | Scalp acupuncture | Clozapine | 33 | 33 | 10 days | ①②③ |
①PSQI score; ②effective rate; ③adverse events.
Figure 2Literature quality risk bias chart.
Figure 3The forest plot of effective rate.
Figure 4The forest plot of PSQI score.
Figure 5The forest plot of adverse events.
Figure 6Sensitivity analysis of effective rate.
Figure 7Sensitivity analysis of adverse events.
Sensitivity analysis of the PSQI score.
| Excluded studies | OR | 95%CI |
|
| Q test |
|---|---|---|---|---|---|
| Zhiqing Le (2020) | −2.05 | [−3.41, −0.69] | 0.003 | 96 |
|
| Xiaopei Feng (2014) | −2.06 | [−3.40, −0.72] | 0.003 | 96 |
|
| HuiKang (2015) | −2.15 | [−3.48, −0.83] | 0.001 | 96 |
|
| YingzhenLi (2011) | −2.01 | [−3.34, −0.68] | 0.003 | 96 |
|
| Jiali Tang (2016) | −2.01 | [−3.34, −0.68] | 0.003 | 96 |
|
| Yingying Mao (2012) | −2.01 | [−3.34, −0.68] | 0.003 | 96 |
|
| Zhibin Liu (2007) | −2.1 | [−3.52, −0.68] | 0.004 | 96 |
|
| Yu Shi (2020) | −2.01 | [−3.38, −0.64] | 0.004 | 96 |
|
| Daopeng Lai (2015) | −2.01 | [−3.34, −0.68] | 0.003 | 96 |
|
| Qiuhe Zhao (2014) | −2.04 | [−3.32, −0.75] | 0.002 | 96 |
|
| Xuanting Gu (2013) | −2.04 | [−3.32, −0.75] | 0.002 | 96 |
|
| Linna Huang (2011) | −2.01 | [−3.34, −0.68] | 0.003 | 96 |
|
| Zhangling Zhou (2010) | −2.01 | [−3.34, −0.68] | 0.003 | 96 |
|
| Zhiqiang Zhang (2010) | −2.04 | [−3.32, −0.75] | 0.002 | 96 |
|
| Jiakun Cao (2013) | −2.04 | [−3.32, −0.75] | 0.002 | 96 |
|
| Xinhao Li (2018) | −2.01 | [−3.34, −0.68] | 0.003 | 96 |
|
| Jianping Dong (2008) | −2.01 | [−3.34, −0.68] | 0.003 | 96 |
|
| Lianhe Dong (2012) | −2.01 | [−3.34, −0.68] | 0.003 | 96 |
|
| Dong (2018) | −1.53 | [−2.31, −0.74] | 0.0001 | 88 |
|
Figure 8Meta-regression analysis of PSQI score.
Figure 9(a) The funnel plot of effective rate; (b) the funnel plot of PSQI score.
Figure 10Egger's test results of effective rate.
Figure 11Egger's test results of PSQI score.